Cytiva

Trending Articles

  1. CARBOGEN AMCIS introduces SPRINT for early-phase development A new, phase-appropriate approach designed to accelerate early-phase progression while maintaining scientific rigour
  2. Free workshop – Measuring and characterising polymers workshop Anton Paar UK announces 2026 Polymer Processing and Characterisation Workshop in Luton
  3. FDA inspections and Form 483 responses: What companies need to know NSF experts explain how companies can strengthen Form 483 responses, improve CAPA planning and reduce regulatory risk following FDA inspections
  4. CSL's Seqirus discontinues production of Benpen amid generic competition The company cited competition from generics as its reason behind the discontinuation, with the TGA saying that supply of the injection will continue until existing stock is gone
  5. Shimadzu launches integrated HPLC/UHPLC systems These compact, robust instruments feature Analytical Intelligence with auto-diagnostics and auto-recovery, reducing downtime and operator workload

Upcoming event

CPhI North America

2–4 June 2026 | Exhibition | Pennsylvania, US See all

Related Content

Digital

Cytiva launches next-generation Biacore 8 SPR systems for accelerated drug discovery

The company has introduced its new Biacore 8S and 8S+ surface plasmon resonance systems, combining high-throughput screening, molecular characterisation and automated workflows to support faster and more confident drug discovery
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

From bespoke to scalable: closing the manufacturing gap in advanced therapeutics

Dr Kevin Robinson (KSR) spoke to Cytiva’s Nicolas Pivet (NP), Vice President of Manufacturing and Digital Solutions, to find out how digitalisation and scalable manufacturing platforms are shaping the next phase of advanced therapeutics
Digital

Rockwell Automation and Cytiva launch Figurate SCADA system to eliminate digital bottlenecks in biopharmaceutical manufacturing

The pair have jointly launched an open-architecture supervisory control platform, designed to integrate across multiple instrument vendors and modalities, providing biopharma manufacturers with unified real-time process oversight from development through to commercial scale
You need to be a subscriber to read this article.
Click here to find out more.
Research & Development

Cytiva enters research partnership with SRTIGET for next-gen genomic medicine

The pair aim to expand the role of lipid nanoparticle technology into gene therapy delivery, including applications in cancer and inherited blood diseases, CNS delivery for neurological disorders where current methods fail and in vivo stem cell modification that could eliminate toxic conditioning regimens
Pharmaceutical

Cytiva and Fida Biosystems unite to improve molecular insight for faster drug discovery

The collaboration will combine complementary and orthogonal approaches to simplify workflows and improve confidence in experimental results
Research & Development

Certified biobased resins bring sustainable lab filtration to Cytiva’s customers

Certified materials enable labs to choose more sustainable options without changing workflows or compromising performance
Analysis

Global biopharma faces talent shortages and regulatory uncertainty, Cytiva’s 2025 Global Biopharma Index finds

Cytiva’s latest Global Biopharma Index, surveying 1250 executives across 22 countries, reveals that while supply chain resilience is improving, talent shortages and policy instability are threatening growth across the biopharma sector
Subscribe now